1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024Efficacy of ETB-F01, Heat-Killed Akkermansia muciniphila Strain EB-AMDK19, in Patients with Respiratory Symptoms: A Multicenter Clinical Trial NUTRIENTS
2025Assessing the Economic Impact of Cancer Care: A Study on Out-of-Pocket Expenditures and Utilization in South Korea CANCER MEDICINE
2025Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening for the Phase III FORTITUDE-101 Trial JCO PRECISION ONCOLOGY
2025INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric CancerJOURNAL OF CLINICAL ONCOLOGY
2025Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer NEW ENGLAND JOURNAL OF MEDICINE
2025Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications EUROPEAN JOURNAL OF CANCER
2025Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials CLINICAL GENITOURINARY CANCER
2025Accelerated Early Discharge and Clinical Outcomes in Heart Failure Patients With Cardiac Implantable Electronic Devices - Subanalysis From a Multicenter Cohort Study CIRCULATION JOURNAL
2025Sex differences in the risk of incident systemic sclerosis: a nationwide population-based study with subgroup analyses SCIENTIFIC REPORTS
2025Enhancing Lymph Node Metastasis Risk Prediction in Early Gastric Cancer Through the Integration of Endoscopic Images and Real-World Data in a Multimodal AI Model CANCERS
2025Genome wide interaction study of genetic variants associated with lung function declineSCIENTIFIC REPORTS
2025Statin use and liver-related prognosis among patients with MASLD JHEP REPORTS
2024Plain language summary: tarlatamab for patients with previously treated small cell lung cancer FUTURE ONCOLOGY
2024Remnant cholesterol as a residual risk in atherosclerotic cardiovascular disease patients under statin-based lipid-lowering therapy: A post hoc analysis of the RACING trialJOURNAL OF CLINICAL LIPIDOLOGY
2024Association between mechanical power and intensive care unit mortality in Korean patients under pressure-controlled ventilation ACUTE AND CRITICAL CARE
2024Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing studyFUTURE ONCOLOGY
2024Causal effect of fasting serum glucose on atherosclerotic cardiovascular disease: a multivariable Mendelian randomization EPIDEMIOLOGY AND HEALTH
2024Reinforcing treatment and evaluation workflow of stereotactic ablative body radiotherapy for refractory ventricular tachycardia RADIATION ONCOLOGY JOURNAL
2024Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patientsHEPATOLOGY INTERNATIONAL
2024Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial GASTRIC CANCER

Recent Submissions

Browse

Links